Variability in clopidogrel pharmacokinetics among patients has been appreciated for years and this results in inconsistent effects on platelet inhibition and poor outcomes. Multiple strategies to personalize antiplatelet therapy intended to balance the risks and benefits of therapy have been tested. A recent systematic review and meta-analysis attempts to answer the question: Is a personalized approach worth it?
Guest Authors: Kiana R. Green, PharmD and Augustus (Rob) Hough, PharmD, BCPS, BCCP
Music by Good Talk
Top Ten Things Every Clinician Should Know About Infographics
Mind Over Migraine: Can Mindfulness Improve Outcomes?
Is Home Blood Pressure Monitoring a “Home Run” for Blood Pressure Management?
Increasing the Patient-Clinician Connection: the “Presence 5 Practices”
FAST Take: Update on Febuxostat Cardiovascular Safety
Metformin During Pregnancy: Are the Results MiTy Enough to Change Practice?
Can a Polypill ‘TIP’ the Scale to a One-Size-Fits All Approach?
There’s an App for That! Can Smartphone Apps Assist with Smoking Cessation?
DECLARE-ing Another Victory for Dapagliflozin
Closing the Loop for Children with Type 1 Diabetes
Is it Time to Add Colchicine to the CVD Cocktail?
Canagliflozin Comeback? New Data on the Risk of Amputation
Using shared decision-making tools: Are they worth it?
Less Might Be Better: Deprescribing Antihypertensive Medications in Older Adults
Extracting Data on CBD: Effects on Opioid Use and Quality of Life
I Screen, You Screen, We Should All Screen for Unhealthy Drug Use
Implementing Comprehensive Medication Management – Ingredients for Success
Can VOYAGER Put PAD Patients Back on Their Feet?
Will Bempedoic Acid provide SERENITY for Patients with Statin Intolerance?
No Provider Status, No Problem: CCM as a Revenue Source in Community Pharmacy
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive